相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer
James L. Mohler et al.
CANCER RESEARCH (2011)
Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression
Yingming Li et al.
CANCER RESEARCH (2011)
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors
Christiane M. Robbins et al.
GENOME RESEARCH (2011)
The genomic complexity of primary human prostate cancer
Michael F. Berger et al.
NATURE (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
Genome-wide mapping and assembly of structural variant breakpoints in the mouse genome
Aaron R. Quinlan et al.
GENOME RESEARCH (2010)
Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant
Shihua Sun et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Treatment-Dependent Androgen Receptor Mutations in Prostate Cancer Exploit Multiple Mechanisms to Evade Therapy
Mara P. Steinkamp et al.
CANCER RESEARCH (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Ligand-Independent Androgen Receptor Variants Derived from Splicing of Cryptic Exons Signify Hormone-Refractory Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2009)
Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
Margaret A. Leversha et al.
CLINICAL CANCER RESEARCH (2009)
Anti-androgens and androgen-depleting therapies in prostate cancer: new agents for an established target
Yu Chen et al.
LANCET ONCOLOGY (2009)
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
Wennuan Liu et al.
NATURE MEDICINE (2009)
Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
Scott M. Dehm et al.
CANCER RESEARCH (2008)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Maintenance of intratumoral androgens in metastatic prostate cancer: A mechanism for castration-resistant tumor growth
R. Bruce Montgomery et al.
CANCER RESEARCH (2008)
Androgen-Regulated and Highly Tumorigenic Human Prostate Cancer Cell Line Established from a Transplantable Primary CWR22 Tumor
Ayush Dagvadorj et al.
CLINICAL CANCER RESEARCH (2008)
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
Hannelore V. Heemers et al.
ENDOCRINE REVIEWS (2007)
Drug Insight: role of the androgen receptor in the development and progression of prostate cancer
Mary-Ellen Taplin
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The androgen axis in recurrent prostate cancer
JL Mohler et al.
CLINICAL CANCER RESEARCH (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
The androgen receptor gene mutations database (ARDB): 2004 update
B Gottlieb et al.
HUMAN MUTATION (2004)
Androgen receptor gene amplification and protein expression in recurrent prostate cancer
OH Ford et al.
JOURNAL OF UROLOGY (2003)
Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer
J Edwards et al.
BRITISH JOURNAL OF CANCER (2003)
Androgen receptor mutations in androgen-in dependent prostate cancer: Cancer and Leukemia Group B Study 9663
ME Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone
MP Roudier et al.
HUMAN PATHOLOGY (2003)
LuCaP 35: A new model of prostate cancer progression to androgen independence
E Corey et al.
PROSTATE (2003)
Androgen receptor mutations in high-grade prostate cancer before hormonal therapy
J Thompson et al.
LABORATORY INVESTIGATION (2003)
Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer
ER Hyytinen et al.
LABORATORY INVESTIGATION (2002)
Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide
K Haapala et al.
LABORATORY INVESTIGATION (2001)
分享论文
